[1]
2026. CONTRIBUTION OF EDN1 AND COMT GENE VARIATIONS TO THE DEVELOPMENT OF CARDIOTOXIC COMPLICATIONS. Eureka Journal of Health Sciences & Medical Innovation. 2, 1 (Jan. 2026), 743–753.